Verizon Communications Inc. (BAC)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 39.73 |
|---|---|
| 52-week range | 32.60 – 45.00 |
| Return, 1 month / 3 months | −2.2% / +3.3% |
| Return, 1 year / 3 years | +22.8% / +61.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 27.0% |
| Worst drawdown (1 year) | -18.1% |
| Average daily value traded | 0.22M EUR |
| Dividend yield | 5.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Verizon Communications is a telecommunications company based in the United States that provides wireless voice and data services, broadband internet and fixed-line telephone connections. It serves individual consumers, small businesses and large organisations, offering mobile plans, home internet and enterprise networking services. The company also supplies related equipment and connectivity solutions, and its services are used across the country by customers who rely on its mobile and broadband networks for everyday communication and business operations.
Verizon Communications Inc. trades under the code BAC on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Verizon Communications Inc. (BAC) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 39.73 on 22 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 124 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 22.8% and over the last three months it rose 3.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.3% | ||
| From 52-week high | -11.4% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.3% | ||
| 6-month return | 5.0% | ||
| 12-month return, skipping the last month | 25.5% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 27.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.1% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.22M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.6% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.8% |
|---|---|
| 1 month | −2.2% |
| 3 months | +3.3% |
| 6 months | +5.0% |
| 1 year | +22.8% |
| 3 years | +61.1% |
| 5 years | +19.7% |
Signals
| 50-day / 200-day average | 41.12 / 39.21 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.93 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Oct 2026 | USD 0.6293 |
| 10 Jul 2026 | USD 0.6293 |
| 10 Apr 2026 | USD 0.6293 |
| 12 Jan 2026 | USD 0.6138 |
| 10 Oct 2025 | USD 0.6138 |
| 10 Jul 2025 | USD 0.6026 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.